₹1 Lakh Crore RDI Fund Stalls as TDB Stops Applications, Awaiting DST’s Money

The news

New Delhi. The Technology Development Board (TDB), a statutory body under the Department of Science and Technology (DST), posted a notice on September 29 that funding invitations will close after this month “due to administrative reasons”, The Indian Express reports. Sources say the TDB, the only agency now selecting beneficiaries for the ₹1 lakh crore RDI Fund, has not received money for fresh offers, though the DST, the fund’s custodian, has been allocated ₹23,000 crore. The TDB’s ₹2,000 crore ran out in April, when 22 firms were offered soft loans of ₹2,192 crore; 13 more selected in August have no letters of intent. Selection is meant to run through “Second Level Fund Managers” (SLFMs), intermediaries that pick and finance firms, but the 30-40 private SLFMs expected have not been appointed. The syllabus link is GS3 on mobilisation of resources and indigenisation of technology.

Static syllabus linkage

1. The RDI scheme lends through two tiers, with ANRF at the top. A special-purpose fund within the Anusandhan National Research Foundation (ANRF) is the first tier; it passes money to Second Level Fund Managers, which lend to or invest in firms in sunrise sectors such as quantum, space and AI. ANRF was set up under the Anusandhan National Research Foundation Act, 2023, which repealed the Science and Engineering Research Board Act, 2008.
2. TDB is a statutory lender to industry; BIRAC is a company. The Technology Development Board was constituted under the Technology Development Board Act, 1995, to give loans and equity support to firms commercialising indigenous technology. The Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit company under the Department of Biotechnology, so dividends from loans converted into equity raise tax questions for it that a statutory board does not face.

Why UPSC loves this

1. Private R&D is where India’s innovation gap sits. GS3 lists “Indigenization of technology and developing new technology”. India spends well under 1% of GDP on research, with business funding only about two-fifths, so innovation answers now need the RDI Fund.

Analysis

1. Private firms under-invest in research for three reasons the market cannot fix alone. Research is risky: most projects fail, which banks cannot price. It is slow: deep-tech revenue can take longer than venture funds wait. And its gains leak: rivals and the wider economy benefit without paying, so the inventor captures only part of the value. This market failure from risk, gestation and spillovers is why patient public capital is justified.
2. Lens — Market and State: the State chose the right instrument but built it without a delivery pipe. Letting private fund managers pick firms is sound, since officials judge start-ups poorly. But the design depended on private SLFMs, a tax ruling and timely DST releases, and none arrived. When the State relies on the market to allocate, it must still do its own part fast. A thoughtful officer would write release schedules and SLFM deadlines into the scheme, so one late file cannot stop the fund.
3. The conflict-of-interest row makes speed and integrity look like enemies; they are not. The Indian Express reported on August 10 that 15 of the first 22 recipients had investment ties to seven selection-committee members, who said they recused themselves. The answer is not slower selection but published recusals, scores and reasons.

Administrator's brainstorm